Neoplasia/BPH

	Evidence-based perioperative nutritional management for patients undergoing prostate cancer surgery: a systematic review. Gland Surg Mao Y, Chen T, Chen J, Luo M, Wu Q, Zhu J, Chen Y. PMID: 42299296 [PubMed]
	Comprehensive bioinformatics and experimental analysis of PPOX reveals its carcinogenic effect in clear cell renal cell carcinoma. Transl Androl Urol Wang K, Wang L, Zhang Y, Hou D, Kang L, Qin Z, Zhu X, Li C, Wang H. PMID: 42299266 [PubMed]
	False-Positive Prostate-Specific Membrane Antigen (PSMA) PET Uptake in the Vocal Cords Mimicking Metastatic Disease in Prostate Cancer: A Case Report Highlighting Diagnostic Pitfalls. Cureus Ameur Y, Tetou M, Oukouhou A, Harchaoui MA, Mrabti M, Boukhlifi Y, El Bahri A, Alami M, Ameur A. PMID: 42299189 [PubMed]
	da Vinci(®) single-port versus da Vinci(®) Xi multiport robot-assisted radical prostatectomy for localized prostate cancer: a GRADE-assessed systematic review and meta-analysis. BMC Surg Mirza W, Aslam MB, Ammar M, Ali RN, Moeen-Ud-Din MB, Hadhoud AM. PMID: 42298538 [PubMed - as supplied by publisher]
	Metacognitions and Reproductive Concerns in Testicular Cancer Patients of Reproductive Age: The Mediating Role of Fear of Progression. Cancer Med Hu Y, Zhou J, Fu C, Ye Y, Zheng X, Lu H, Li X, Chen G, Liu F, Lai B, Fu X. PMID: 42298302 [PubMed - indexed for MEDLINE]
	Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score-matched retrospective study. Eur J Clin Pharmacol Sato A, Sumimoto T, Tanaka R, Tatsuta R, Yoshikawa N, Itoh H. PMID: 42298206 [PubMed - indexed for MEDLINE]
	Evaluating the Diagnostic Performance of Clear Cell Likelihood Score in Predicting Clear Cell Renal Cell Carcinoma Among Patients Younger Than 50 Years. JCO Oncol Pract Abdollahzadeh A, Lahiji R, Harris M, Patil D, Gupta A, Majeed NF, Sekhar A, Palmateer G, Morton EA, Ramacciotti LS, Grajales V, Joshi SS, Narayan VM, Nabavizadeh R, Hajiha M, Pedrosa I, Ogan K, Master VA. PMID: 42296450 [PubMed - as supplied by publisher]
	Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer. Immunol Res Weng M, Wang X, Zhan Y, Guo Y, Yan Z, Qu L, Liu Y, Chen C. PMID: 42295562 [PubMed - indexed for MEDLINE]
	Patient-Reported Outcomes on Quality of Life and Psychological Distress After Focal High-Intensity Focused Ultrasound for Prostate Cancer: Prospective Multicenter Study. JMIR Cancer Franz T, Hartung C, Ganzer R, Holze S, Stolzenburg JU. PMID: 42295325 [PubMed - indexed for MEDLINE]
	Preliminary clinical association between the Nerve-Sparing Quality (NSQ) Score and early functional outcomes after robot-assisted radical prostatectomy. Folia Med Cracov Kempisty J, Balawander K, D, Burdziak K. PMID: 42295074 [PubMed - indexed for MEDLINE]
	Intraoperative Hypotension During Photodynamic Diagnosis-Guided TURBT Under Spinal Anesthesia: A Propensity Score-Matched and Logistic Regression Analysis. Int J Urol Igarashi A, Kinoshita T, Fujita M, Obayashi R, Yamamoto A, Yamamoto R, Akagi N, Shibasaki N, Kawakita M, Yamasaki T. PMID: 42295047 [PubMed - indexed for MEDLINE]
	Multi-Center, Real-World Registry Study of the UroLift Prostatic Urethral Lift (PUL) for Benign Prostatic Hyperplasia (BPH) in Japan. Int J Urol Masumori N, Takahashi S, Anan G, Endo F, Furuta A, Haga K, Hatanaka M, Kato S, Komai Y, Kyoda Y, Matsuyama N, Murayama S, Nagamatsu H, Obinata D, Sekiguchi Z, Waseda Y. PMID: 42294858 [PubMed - indexed for MEDLINE]
	TURBT versus RC in T1N0M0 non-urothelial bladder cancer: a population-based study. Front Oncol He Q, Chen Y, Zhang T, Sheng W, Huang J. PMID: 42294298 [PubMed]
	Development and validation of a machine learning-based radiomics model using 45-keV virtual monoenergetic images for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma. Transl Androl Urol Jing S, Wang J, Zhao X, Zeng B, Luo J, Yang Z, Liu Y. PMID: 42293856 [PubMed]
	NOX4 suppresses malignant progression in prostate adenocarcinoma and functions as a potential diagnostic biomarker. Transl Androl Urol Hu J, Zhou M, Wu X, Hu M. PMID: 42293855 [PubMed]
	Future direction of systemic therapy for advanced renal cell carcinoma: lessons from final and extended follow-up data from the CheckMate 9ER trial. Transl Androl Urol Ishihara H. PMID: 42293852 [PubMed]
	Electrolyte trajectory-based subphenotypes and their association with hospital length of stay in prostate cancer patients. Transl Androl Urol Shen Y, Xuan H, Wang J, Hu Y, Zhang Y. PMID: 42293848 [PubMed]
	Diagnostic potential of urinary PENK methylation for bladder cancer in patients with hematuria: insights from a prospective and multi-institutional study. Transl Androl Urol Koguchi D, Shiba I, Shiono Y, Matsumoto K. PMID: 42293844 [PubMed]
	Analysis of factors affecting the upstaging and downstaging of renal cell carcinoma from T1 to T3a and the impact of different surgical approaches on patient prognosis and survival: a multicenter retrospective study. Transl Androl Urol Zhang Y, Baerbieke Y, Fan J, Ma C, Zhuang Y, Li J, Wang Z, Zeng J, Shi X, Yang T, Pei X, Li X. PMID: 42293838 [PubMed]
	Association between prognostic nutritional index (PNI)/Controlling Nutritional Status (CONUT) score and prognosis in patients with bladder cancer: a systematic review and meta-analysis. Transl Androl Urol Chen Y, Zheng J, Li D, Wu Q, Ren Q. PMID: 42293833 [PubMed]

Articles 1 - 20 / 188666

Page 1 of 9434



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy